Partner Content Partner Content Explore New Strategies for Treating Retinal Vascular Disease... Ophthalmic Drugs 2018
Partner Content Partner Content Exclusive Speaker Interview for SMI’s Inaugural Cell & G... Speaker Interview for Cell & Gene Therapy 2018
Partner Content Partner Content Explore the future of ocular gene editing and strategic drug... Ophthalmic Drugs Conference
Partner Content Partner Content 1 week remaining for the 6th Pharmaceutical Freeze Drying Te... Pharmaceutical Freeze Drying Technology - Lyophilisatio
Partner Content Partner Content Explore the latest developments in ATMPs at Cell & Gene ... Cell and Gene Therapy 2018
Partner Content Partner Content Discover the Future of Pharmaceutical Technology Within Lyop... Pharmaceutical Freeze Drying Technology
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
